Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.
Aringer M, Burkhardt H, Burmester GR, Fischer-Betz R, Fleck M, Graninger W, Hiepe F, Jacobi AM, Kötter I, Lakomek HJ, Lorenz HM, Manger B, Schett G, Schmidt RE, Schneider M, Schulze-Koops H, Smolen JS, Specker C, Stoll T, Strangfeld A, Tony HP, Villiger PM, Voll R, Witte T, Dörner T. Aringer M, et al. Among authors: burkhardt h. Lupus. 2012 Apr;21(4):386-401. doi: 10.1177/0961203311426569. Epub 2011 Nov 9. Lupus. 2012. PMID: 22072024 Review.
Immunological treatment of autoimmune diseases.
Kalden JR, Breedveld FC, Burkhardt H, Burmester GR. Kalden JR, et al. Among authors: burkhardt h. Adv Immunol. 1998;68:333-418. doi: 10.1016/s0065-2776(08)60564-7. Adv Immunol. 1998. PMID: 9505094 Review. No abstract available.
Chicken and egg in autoimmunity and joint inflammation.
Burkhardt H, Kalden JR, Schulze-Koops H. Burkhardt H, et al. Trends Immunol. 2001 Jun;22(6):291-3. doi: 10.1016/s1471-4906(01)01935-4. Trends Immunol. 2001. PMID: 11419408 No abstract available.
[Presentation of the Erlangen Competence Center].
Rautenstrauch J, Burkhardt H, Schulze-Koops H, Wassmuth R, Harrer T, Spriewald B, Manger B, Kalden JR. Rautenstrauch J, et al. Among authors: burkhardt h. Z Rheumatol. 2001 Dec;60(6):496-505. doi: 10.1007/pl00007333. Z Rheumatol. 2001. PMID: 11826750 German. No abstract available.
[Current therapeutic strategy for rheumatoid arthritis].
Wollenhaupt J, Alten R, Burkhardt H, Edelmann E, Gromnica-Ihle E, Krause A, Krüger K, Manger B, Lorenz H, Müller-Ladner U, Nüsslein H, Pott HG, Tony H, Schneider M. Wollenhaupt J, et al. Among authors: burkhardt h. MMW Fortschr Med. 2006 Oct 19;148(42):38-42; quiz 43. MMW Fortschr Med. 2006. PMID: 17621798 German.
Antibodies to the endoplasmic reticulum-resident chaperones calnexin, BiP and Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus.
Weber CK, Haslbeck M, Englbrecht M, Sehnert B, Mielenz D, Graef D, Distler JH, Mueller RB, Burkhardt H, Schett G, Voll RE, Fürnrohr BG. Weber CK, et al. Among authors: burkhardt h. Rheumatology (Oxford). 2010 Dec;49(12):2255-63. doi: 10.1093/rheumatology/keq272. Epub 2010 Aug 17. Rheumatology (Oxford). 2010. PMID: 20716673
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.
Buch MH, Smolen JS, Betteridge N, Breedveld FC, Burmester G, Dörner T, Ferraccioli G, Gottenberg JE, Isaacs J, Kvien TK, Mariette X, Martin-Mola E, Pavelka K, Tak PP, van der Heijde D, van Vollenhoven RF, Emery P; Rituximab Consensus Expert Committee. Buch MH, et al. Ann Rheum Dis. 2011 Jun;70(6):909-20. doi: 10.1136/ard.2010.144998. Epub 2011 Mar 6. Ann Rheum Dis. 2011. PMID: 21378402 Free PMC article.
408 results